These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3891223)

  • 21. Dialyzer performance in the clinic: comparison of six low-flux membranes.
    Kerr PG; Lo A; Chin Mm; Atkins RC
    Artif Organs; 1999 Sep; 23(9):817-21. PubMed ID: 10491028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute intradialytic well-being: results of a clinical trial comparing polysulfone with cuprophan. Bergamo Collaborative Dialysis Study Group.
    Kidney Int; 1991 Oct; 40(4):714-9. PubMed ID: 1745022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initial clinical evaluation of 'diafiltration'.
    Shinaberger JH; Miller JH; Rubini ME; Gardner PW; Martin FE
    Trans Am Soc Artif Intern Organs; 1969; 15():97-102. PubMed ID: 5791437
    [No Abstract]   [Full Text] [Related]  

  • 24. The Removal of β2-Microglobulin in Spent Dialysate Cannot Be Monitored by Spectrophotometric Analysis.
    Donadio C; Calia D; Ghimenti S; Onor M; Colombini E; Fuoco R; Di Francesco F
    Blood Purif; 2015; 40(2):109-12. PubMed ID: 26183959
    [No Abstract]   [Full Text] [Related]  

  • 25. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
    Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
    Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clearance of aluminium desferrioxamine by haemodialysis using a polysulfone high flux membrane.
    Day JP; Hewitt CD; Ackrill P; Hill K
    Contrib Nephrol; 1989; 74():101-5. PubMed ID: 2702125
    [No Abstract]   [Full Text] [Related]  

  • 27. Biocompatible membranes preserve residual renal function in patients undergoing regular hemodialysis.
    Hartmann J; Fricke H; Schiffl H
    Am J Kidney Dis; 1997 Sep; 30(3):366-73. PubMed ID: 9292565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical studies of 'low flow' dialysis with membranes highly permeable to middle weight molecules.
    Shinaberger JH; Miller JH; Rosenblatt MG; Gardner PW; Carpenter GW; Martin FE
    Trans Am Soc Artif Intern Organs; 1972; 18(0):82-4. PubMed ID: 4679919
    [No Abstract]   [Full Text] [Related]  

  • 29. Adsorption of human recombinant erythropoietin on dialysis membranes in vitro.
    Mori H; Hiraoka K; Yorifuji R; Iwasaki T; Gomikawa S; Inagaki O; Inoue S; Takamitsu Y; Fujita Y
    Artif Organs; 1994 Oct; 18(10):725-8. PubMed ID: 7832652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Research into the development of a wearable bioartificial kidney with a continuous hemofilter and a bioartificial tubule device using tubular epithelial cells.
    Saito A
    Artif Organs; 2004 Jan; 28(1):58-63. PubMed ID: 14720290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of dialysis membrane on serum beta 2-microglobulin (beta 2M) in chronic haemodialysis patients.
    Farrell J; Bastani B
    Nephrol Dial Transplant; 1997 Apr; 12(4):856. PubMed ID: 9141041
    [No Abstract]   [Full Text] [Related]  

  • 32. Fate of beta-2-microglobulin during dialysis on polysulfone and AN69 membranes.
    Goldman M; Nortier J; Dhaene M; Amraoui Z; Vanherweghem JL
    Contrib Nephrol; 1989; 74():127-31. PubMed ID: 2702129
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study.
    Gastaldello K; Melot C; Kahn RJ; Vanherweghem JL; Vincent JL; Tielemans C
    Nephrol Dial Transplant; 2000 Feb; 15(2):224-30. PubMed ID: 10648669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers.
    McCarthy JT; Jenson BM; Squillace DP; Williams AW
    Am J Kidney Dis; 1997 Apr; 29(4):576-83. PubMed ID: 9100048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clearance studies in patients with acute renal failure treated by continuous arteriovenous haemodialysis.
    Davies SP; Kox WJ; Brown EA
    Contrib Nephrol; 1991; 93():117-9. PubMed ID: 1802558
    [No Abstract]   [Full Text] [Related]  

  • 36. The Vivacell--a sterile, disposable, high performance, low prime hemodialyzer.
    Soroka RJ; Rose FL; Esmond WG
    Trans Am Soc Artif Intern Organs; 1973; 19():105-8. PubMed ID: 4722725
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hemodiafiltration using a polysulfone membrane, its ultrafiltration characteristics and biocompatibility].
    Iarmolinskiĭ IS; Stetsiuk EA; Iarmagomedov AA
    Urol Nefrol (Mosk); 1987; (2):45-9. PubMed ID: 3590419
    [No Abstract]   [Full Text] [Related]  

  • 38. Biocompatibility study on cuprophane and polysulphone dialysers.
    Taraba I; Polner K; Makó J
    Nephrol Dial Transplant; 1991; 6 Suppl 3():22-5. PubMed ID: 1775261
    [No Abstract]   [Full Text] [Related]  

  • 39. The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial.
    Kerr PG; Sutherland WH; de Jong S; Vaithalingham I; Williams SM; Walker RJ
    Am J Kidney Dis; 2007 Apr; 49(4):533-9. PubMed ID: 17386321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.